X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4750) 4750
Newsletter (221) 221
Book Chapter (36) 36
Dissertation (18) 18
Magazine Article (18) 18
Newspaper Article (8) 8
Conference Proceeding (7) 7
Web Resource (2) 2
Book / eBook (1) 1
Book Review (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
linezolid (4567) 4567
science & technology (3038) 3038
life sciences & biomedicine (2907) 2907
humans (2673) 2673
microbiology (1446) 1446
pharmacology & pharmacy (1359) 1359
infectious diseases (1280) 1280
male (1140) 1140
microbial sensitivity tests (1054) 1054
anti-bacterial agents - pharmacology (1041) 1041
female (1029) 1029
oxazolidinones - therapeutic use (1014) 1014
acetamides - therapeutic use (1006) 1006
oxazolidinones - pharmacology (941) 941
acetamides - pharmacology (895) 895
anti-bacterial agents - therapeutic use (874) 874
vancomycin (772) 772
middle aged (734) 734
antibiotics (706) 706
adult (623) 623
aged (592) 592
drug resistance (582) 582
staphylococcal infections - drug therapy (561) 561
drug resistance in microorganisms (501) 501
staphylococcus aureus (497) 497
research (488) 488
treatment outcome (477) 477
biochemical phenomena, metabolism, and nutrition (460) 460
staphylococcal infections - microbiology (443) 443
staphylococcus aureus - drug effects (440) 440
oxazolidinones - adverse effects (423) 423
acetamides - adverse effects (410) 410
oxazolidinones - administration & dosage (410) 410
acetamides - administration & dosage (407) 407
gram-positive bacterial infections - drug therapy (406) 406
health aspects (395) 395
animals (393) 393
anti-infective agents - therapeutic use (390) 390
bacteria (374) 374
bacterial infections and mycoses (369) 369
drug resistance, bacterial (368) 368
staphylococcus infections (342) 342
methicillin-resistant staphylococcus aureus - drug effects (334) 334
daptomycin (331) 331
drug therapy (329) 329
anti-bacterial agents - administration & dosage (326) 326
vancomycin - therapeutic use (314) 314
oxazolidinones (294) 294
gram-positive bacterial infections - microbiology (289) 289
vancomycin - pharmacology (288) 288
care and treatment (283) 283
antimicrobial agents (281) 281
methicillin-resistant staphylococcus aureus (278) 278
oxazolidinones - pharmacokinetics (274) 274
anti-bacterial agents - adverse effects (273) 273
infections (269) 269
acetamides - pharmacokinetics (268) 268
methicillin resistance (266) 266
retrospective studies (260) 260
aged, 80 and over (256) 256
immunology (253) 253
analysis (251) 251
pneumonia (250) 250
staphylococcus aureus infections (250) 250
tuberculosis (248) 248
risk factors (247) 247
linezolid - pharmacology (246) 246
anti-infective agents - pharmacology (238) 238
methicillin (237) 237
linezolid - therapeutic use (230) 230
general & internal medicine (228) 228
mrsa (228) 228
hospitals (227) 227
infectious disease (218) 218
anti-bacterial agents - pharmacokinetics (212) 212
adolescent (211) 211
antibacterial agents (209) 209
dosage and administration (206) 206
drug therapy, combination (205) 205
anti-infective agents - adverse effects (204) 204
internal medicine (200) 200
drug resistance, multiple, bacterial (193) 193
infection (189) 189
patients (187) 187
enterococcus faecium - drug effects (184) 184
vancomycin resistance (184) 184
methicillin-resistant staphylococcus aureus - isolation & purification (178) 178
medical research (177) 177
antibiotic resistance (173) 173
cross infection - drug therapy (172) 172
physical fitness (172) 172
child (167) 167
pharmacology (167) 167
gram-positive bacteria (165) 165
young adult (165) 165
gram-positive bacteria - drug effects (162) 162
medicine (160) 160
mutation (156) 156
nosocomial infections (155) 155
medicine, experimental (154) 154
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4690) 4690
Spanish (121) 121
Japanese (71) 71
French (65) 65
Chinese (57) 57
German (38) 38
Turkish (37) 37
Portuguese (30) 30
Russian (23) 23
Italian (17) 17
Korean (14) 14
Polish (5) 5
Swedish (5) 5
Czech (4) 4
Danish (3) 3
Dutch (3) 3
Romanian (3) 3
Norwegian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Croatian (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of antimicrobial chemotherapy, ISSN 1460-2091, 02/2015, Volume 70, Issue 6, pp. 1625 - 1629
Journal Article
Internal medicine (Tokyo, 1992), ISSN 0918-2918, 2019
Linezolid is a useful drug for treating drug-resistant tuberculosis. However, the associated toxicities, especially optic neuritis, are a major obstacle for... 
MDR-TB | neuropathy | linezolid
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2019, Volume 380, Issue 6, pp. 528 - 538
Journal Article
PLoS medicine, ISSN 1549-1676, 04/2019, Volume 16, Issue 4, pp. e1002789 - e1002789
Background Linezolid is increasingly important for multidrug-resistant tuberculosis (MDR-TB) treatment. However, among children with MDR-TB, there are no... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antitubercular Agents - adverse effects | Prospective Studies | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Tuberculosis, Multidrug-Resistant - metabolism | Dose-Response Relationship, Drug | Antitubercular Agents - pharmacokinetics | Adolescent | Linezolid - adverse effects | Antitubercular Agents - administration & dosage | Linezolid - administration & dosage | Female | South Africa | Drug Monitoring | Linezolid - pharmacokinetics | Child | Tuberculosis, Multidrug-Resistant - drug therapy | Linezolid | Drugs | Complications and side effects | Safety and security measures | Tuberculosis | Analysis | Adverse and side effects | Dosage and administration | Children | Drug therapy | Health aspects | Risk factors | Drug resistance in microorganisms | Bioengineering | Health sciences | Pediatrics | Funding | Childrens health | Systematic review | Drug resistance | Peripheral neuropathy | Human immunodeficiency virus--HIV | Mathematical models | Safety | Drug dosages | Supervision | Monitoring | Parameters | Computer simulation | Anemia | Tutu, Desmond | Antimicrobial agents | Exposure | Pharmacology | Patients | Weight | Children & youth | Medicine | Side effects | Chemotherapy | Infectious diseases | Scaling | Adults | Pharmacokinetics | Index Medicus | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Clinical Chemistry and Laboratory Medicine (CCLM), ISSN 1434-6621, 04/2015, Volume 53, Issue 5, pp. 781 - 791
Journal Article
Journal Article
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and The Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet (British edition), ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems | Index Medicus | Abridged Index Medicus
Journal Article